Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Congenital peripheral primitive neuroectodermal tumor: a case treated successfully with multimodality treatment
Shikha Goyal1, Ahitagni Biswas1, Ruchika Gupta2
1Department of Radiotherapy, All India Institute of Medical Sciences, New Delhi 110029, India.
Neonatal primitive neuroectodermal tumors are rare but treatable. This case highlights successful multimodality therapy for a congenital Ewing's sarcoma family of tumors in an infant, emphasizing the need for improved treatment strategies.
Area of Science:
- Pediatric Oncology
- Neonatal Medicine
- Cancer Biology
Background:
- Neonatal tumors are rare, accounting for less than 2% of childhood cancers.
- Solid tumors, such as teratoma and neuroblastoma, are the most common types in neonates.
- Primitive neuroectodermal tumors (PNETs) represent a challenging diagnostic and therapeutic group in this population.
Observation:
- A congenital right arm mass was detected via antenatal sonogram.
- Post-natal fine needle aspiration cytology diagnosed a primitive neuroectodermal tumor involving the triceps muscle.
- This represents a rare instance of congenital Ewing's sarcoma family of tumors.
Findings:
- The infant was successfully treated using a multimodality approach, including surgery, chemotherapy, and radiotherapy.
- The study reviews reported cases of congenital Ewing's sarcoma family of tumors.
- Challenges in neonatal cancer therapy are discussed, including treatment-related side effects.
Implications:
- Multimodality treatment can be effective for neonatal primitive neuroectodermal tumors.
- There is a critical need for novel therapies to enhance treatment efficacy and reduce toxicity in neonates.
- Further research into congenital Ewing's sarcoma family of tumors is warranted to improve outcomes.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies